First‐line therapies in late‐onset multiple sclerosis: An Italian registry study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First‐line therapies in late‐onset multiple sclerosis: An Italian registry study
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-07-04
DOI
10.1111/ene.15006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- “No evidence of disease activity”: Is it an aspirational therapeutic goal in multiple sclerosis?
- (2020) El Najjar Mayssam et al. Multiple Sclerosis and Related Disorders
- Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis
- (2020) Omid Mirmosayyeb et al. Journal of Clinical Medicine
- Immunosenescence is both functional/adaptive and dysfunctional/maladaptive
- (2020) T. Fulop et al. Seminars in Immunopathology
- Late onset multiple sclerosis is associated with more severe ventricle expansion
- (2020) Dejan Jakimovski et al. Multiple Sclerosis and Related Disorders
- Late onset and young onset relapsing remitting multiple sclerosis. Evidence from a retrospective long-term follow-up study
- (2018) Emanuele D'Amico et al. EUROPEAN JOURNAL OF NEUROLOGY
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Italian multiple sclerosis register
- (2018) Maria Trojano et al. NEUROLOGICAL SCIENCES
- Treatment decisions in multiple sclerosis — insights from real-world observational studies
- (2017) Maria Trojano et al. Nature Reviews Neurology
- Observational data: Understanding the real MS world
- (2016) Tomas Kalincik et al. Multiple Sclerosis Journal
- Observational data: Understanding the real MS world
- (2016) Tomas Kalincik et al. Multiple Sclerosis Journal
- Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
- (2016) Raed Alroughani et al. PLoS One
- Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal
- (2015) Emanuele D’Amico et al. Expert Review of Neurotherapeutics
- Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal
- (2015) Emanuele D’Amico et al. Expert Review of Neurotherapeutics
- Missing data in longitudinal studies: cross-sectional multiple imputation provides similar estimates to full-information maximum likelihood
- (2013) Mark A. Ferro ANNALS OF EPIDEMIOLOGY
- Practical considerations for sensitivity analysis after multiple imputation applied to epidemiological studies with incomplete data
- (2012) Vanina Héraud-Bousquet et al. BMC Medical Research Methodology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now